Trospium
New Schizophrenia Drug Cobenfy (Xanomeline and Trospium Chloride) Gets FDA Approval
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) to treat schizophrenia in adults, offering…
Read More »
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) to treat schizophrenia in adults, offering…
Read More »